5-HT3 receptor antagonists

Expert Opinion on Therapeutic Patents

Volumn 6, Issue 5, 1996, Pages 471-481

  Silverstone, P H ^a   Greenshaw, A J ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

1 ISOPROPYL 6 METHYLERGOLINE 8 CARBOXYLIC ACID 2 HYDROXY 1 METHYLPROPYL ESTER; 1 METHYL 3 INDOLECARBOXYLIC ACID [1 [2 (METHYLSULFONYLAMINO)ETHYL] 4 PIPERIDINYLMETHYL] ESTER; 2 DIPROPYLAMINO 8 HYDROXYTETRALIN; 2 METHYLSEROTONIN; 3 (1,2,5,6 TETRAHYDRO 4 PYRIDYL)PYRROLO[3,2 B]PYRIDIN 5 ONE; 5 METHOXYSEROTONIN; ALPHA METHYLSEROTONIN; ANTIEMETIC AGENT; APOMORPHINE; BEMESETRON; COCAINE; DOLASETRON MESILATE; GRANISETRON; KETANSERIN; MESULERGINE; METOCLOPRAMIDE; N TERT BUTYL 3 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL] 2 PHENYLPROPIONAMIDE; ONDANSETRON; RECEPTOR SUBTYPE; RENZAPRIDE; SEROTONIN; SEROTONIN 3 ANTAGONIST; SEROTONIN 3 RECEPTOR; SEROTONIN AGONIST; SEROTONIN ANTAGONIST; SUMATRIPTAN; TROPISETRON; UNCLASSIFIED DRUG; UNINDEXED DRUG; ZACOPRIDE;

ABUSE; ANALGESIA; ANIMAL MODEL; ANXIETY; CANCER CHEMOTHERAPY; CANCER PATIENT; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL TRIAL; DRUG INDICATION; DRUG RESEARCH; GENERAL ANESTHESIA; HUMAN; IRRITABLE COLON; MIGRAINE; NONHUMAN; PAIN; PATENT; PSYCHOSIS; REVIEW; VOMITING;

EID: 0029882342     PISSN: 13543776     EISSN: None     Source Type: Journal    
DOI: 10.1517/13543776.6.5.471     Document Type: Review

References (0)